Skip to main content
. 2019 Jul 12;17(5):1378–1387. doi: 10.5114/aoms.2019.86609

Figure 5.

Figure 5

Vildagliptin inhibit miR-134-5p in aorta to activate Bdnf to moderate endothelial function; activate miR-190a-5p to inhibit Ccl2; and inhibit miR-375-3p to activate Pdk1 to inhibit apoptosis.

Bdnf – brain-derived neurotrophic factor, Ccl2 – C-C motif chemokine ligand 2, Pdk1 – 3-phosphoinositide dependent protein kinase-1.